Poolbeg Pharma PLC (LON:POLB – Get Free Report) shares were down 8.5% during trading on Friday . The stock traded as low as GBX 2.65 ($0.04) and last traded at GBX 2.70 ($0.04). Approximately 4,186,242 shares were traded during trading, an increase of 99% from the average daily volume of 2,105,809 shares. The stock had previously closed at GBX 2.95 ($0.04).
Poolbeg Pharma Trading Down 3.7 %
The stock has a market cap of £14.60 million, a P/E ratio of 0.00 and a beta of 2.11. The business has a 50-day simple moving average of GBX 2.81 and a 200 day simple moving average of GBX 5.09.
About Poolbeg Pharma
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. Poolbeg comprises a strong and growing portfolio of development assets.
Further Reading
- Five stocks we like better than Poolbeg Pharma
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
- How to Calculate Return on Investment (ROI)
- Here’s The Reason Goldman Sachs Is Bullish On MercadoLibre Stock
- What is diluted earnings per share (Diluted EPS)?
- Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?
Receive News & Ratings for Poolbeg Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Poolbeg Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
